(Q37334992)

English

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen

scientific article published on September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

aplastic anemia

1 reference

based on heuristic

inferred from title

acquired aplastic anemia

1 reference

based on heuristic

inferred from title

6

object named as

Gérard Socié

1 reference

Europe PubMed Central

19 August 2017

author name string

Sébastien Maury

1

1 reference

Europe PubMed Central

19 August 2017

Andrea Bacigalupo

2

1 reference

Europe PubMed Central

19 August 2017

Paolo Anderlini

3

1 reference

Europe PubMed Central

19 August 2017

Mahmoud Aljurf

4

1 reference

Europe PubMed Central

19 August 2017

Judith Marsh

5

1 reference

Europe PubMed Central

19 August 2017

Rosi Oneto

7

1 reference

Europe PubMed Central

19 August 2017

Jakob R Passweg

8

1 reference

Europe PubMed Central

19 August 2017

Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT-SAAWP)

9

1 reference

Europe PubMed Central

19 August 2017

publication date

1 September 2009

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

94

1 reference

Europe PubMed Central

19 August 2017

9

1 reference

Europe PubMed Central

19 August 2017

1312-1315

1 reference

Europe PubMed Central

19 August 2017

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

6 September 2017

Current concepts in the pathophysiology and treatment of aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

6 September 2017

Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

6 September 2017

Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

6 September 2017

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

6 September 2017

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

14 September 2017

Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

26 June 2018

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

2 September 2018

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

2 September 2018

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

2 September 2018

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738727

2 September 2018

Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Study of chimerism in long-term survivors after bone marrow transplantation for severe acquired aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation for severe aplastic anemia: has outcome improved?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acquired aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the diagnosis and management of acquired aplastic anaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19734425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2009.006916

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37334992&oldid=2088916648"